Measurement of the Oxygen Saturation in the Retinal Vessels With Oxymap
NCT ID: NCT02318641
Last Updated: 2018-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2014-12-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retinal Oximtery Following Treatment for Diabetic Maculopathy
NCT01549132
Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap
NCT02521116
Measurement of Retinal Blood Flow, Retinal Oxygenation and Retinal Oxygen Extraction in Healthy Subjects During Normoxia and Systemic Hyperoxia
NCT00914407
Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module
NCT03279939
Short Term and Day to Day Reproducibility of Reflectometric Measurement of Retinal Oxygen Saturation in Healthy Subjects
NCT00991900
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Retinal oximetry in various chorioretinal diseases will be measured with Oxymap.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oximetry
Retinal oximetry will be performed with Oxymap.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kagawa University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Akitaka Tsujikawa
Professor and Chairman
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AKITAKA TSUJIKAWA, MD
Role: PRINCIPAL_INVESTIGATOR
Kagawa Univerisity Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kagawa University Faculty of Medicine
Hiragi, Kagawa-ken, Japan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H26-046
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.